DISCGENICS

discgenics-logo

Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

#SimilarOrganizations #People #Financial #Event #Website #More

DISCGENICS

Social Links:

Industry:
Biotechnology Health Care Life Science Therapeutics

Founded:
2007-11-06

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.discgenics.com

Total Employee:
11+

Status:
Active

Contact:
801-410-0703

Email Addresses:
[email protected]

Total Funding:
68 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx PHP


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

Current Employees Featured

not_available_image

Rand Page
Rand Page Investor @ DiscGenics
Investor

flagg-flanagan_image

Flagg Flanagan
Flagg Flanagan Chairman & CEO @ DiscGenics
Chairman & CEO

not_available_image

John Robertson
John Robertson Founder @ DiscGenics
Founder

not_available_image

Mark Cohen
Mark Cohen Founder @ DiscGenics
Founder

kevin-t-foley_image

Kevin T. Foley
Kevin T. Foley Director & Chief Medical Officer @ DiscGenics
Director & Chief Medical Officer
2008-08-01

bob-wynalek_image

Bob Wynalek
Bob Wynalek Director and Chief Operating & Commercialization Officer @ DiscGenics
Director and Chief Operating & Commercialization Officer

jeff-poole_image

Jeff Poole
Jeff Poole Chief Financial Officer @ DiscGenics
Chief Financial Officer
2020-08-01

not_available_image

Mike Moffat
Mike Moffat Former Executive Officer @ DiscGenics
Former Executive Officer

not_available_image

Valery Kukekov
Valery Kukekov Founder @ DiscGenics
Founder

Founder


not_available_image

Christopher Duntsch

flagg-flanagan_image

Flagg Flanagan

not_available_image

John Robertson

kevin-t-foley_image

Kevin T. Foley

not_available_image

Mark Cohen

not_available_image

Mike Moffat

not_available_image

Rand Page

not_available_image

Valery Kukekov

Investors List

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Series C - DiscGenics

medical-incubator-japan_image

Medical Incubator Japan

Medical Incubator Japan investment in Series C - DiscGenics

ci-z-investment_image

Ci:z Investment

Ci:z Investment investment in Series C - DiscGenics

najeeb-thomas_image

Najeeb Thomas

Najeeb Thomas investment in Series C - DiscGenics

eagle-venture-fund_image

Eagle Venture Fund

Eagle Venture Fund investment in Series C - DiscGenics

carenet_image

CareNet

CareNet investment in Series C - DiscGenics

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Series B - DiscGenics

Official Site Inspections

http://www.discgenics.com Semrush global rank: 2.23 M Semrush visits lastest month: 8.66 K

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "DiscGenics"

Our Company - DiscGenics

DiscGenics, a pioneer in regenerative medicine, has made significant advancements in treating degenerative spine diseases thanks to its visionary founders. Co-founded in 2008 by Dr. โ€ฆSee details»

DiscGenics - Crunchbase Company Profile & Funding

Organization. DiscGenics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โ€ฆSee details»

Our Focus โ€” DiscGenics

At DiscGenics, we are focused on developing regenerative cell-based biologic drug therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. As major contributors to low back pain, โ€ฆSee details»

DiscGenics

The DiscGenics team is full of smart and dedicated individuals all working to provide a cutting-edge therapy for patients. Every day is engaging and exciting, full of learning and growth. I get โ€ฆSee details»

DiscGenics - LinkedIn

DiscGenics | 3,187 followers on LinkedIn. REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN | DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative ...See details»

Discgenics, Inc. Company Profile | Salt Lake City, UT | Competitors ...

Find company research, competitor information, contact details & financial data for Discgenics, Inc. of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»

DiscGenics 2025 Company Profile: Valuation, Funding โ€ฆ

DiscGenics was founded in 2008. Where is DiscGenics headquartered? DiscGenics is headquartered in Salt Lake City, UT. What is the size of DiscGenics? DiscGenics has 42 total employees. What industry is DiscGenics โ€ฆSee details»

DiscGenics - VentureRadar

DiscGenics is harnessing the restorative potential of intervertebral disc cells to develop therapies that the company believes will have a profound impact on millions suffering from the โ€ฆSee details»

DiscGenics Company Profile - Office Locations, Competitors ... - Craft

DiscGenics is a biopharmaceutical company focused on developing regenerative therapies aimed at alleviating pain and restoring function in patients with diseases of the spine. Its product โ€ฆSee details»

What Happened To DiscGenics, Co-Founded By 'Dr.

Jul 15, 2021 DiscGenicsโ€™ current funding amount is $68 million. "Dr. Death" is available to stream on Peacock now. And if you want to dive even deeper into the story, you can also watch the new docuseries "Dr. Death: The Undoctored โ€ฆSee details»

DiscGenics - Funding, Financials, Valuation & Investors - Crunchbase

DiscGenics is funded by 5 investors. Mitsubishi UFJ Capital and Medical Incubator Japan are the most recent investors. Which investors participated in the most funding rounds?See details»

Investors & Media - DiscGenics

Feb 8, 2024 DiscGenics has gained acceptance from the U.S. FDA for the clinical protocols and Chemistry, Manufacturing, and Controls (CMC) clinical development plan for Phase III clinical โ€ฆSee details»

DiscGenics - Contacts, Employees, Board Members, Advisors

Organization. DiscGenics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 9. Number of Board โ€ฆSee details»

New Cell Therapy Could Help Millions Suffering from Back Pain

May 30, 2018 DiscGenics engages CCRM and GE Healthcare to support scale-up efforts for new cell therapy. May 30, 2018 (Toronto, ON, Salt Lake City, UT) -- Degenerative disc disease โ€ฆSee details»

DISCGENICS: 10 in 10 Podcast - Merge Medical

Jul 10, 2023 DiscGenics is committed to revolutionizing the way millions of patients suffering from chronic back pain will be treated through a focus on developing regenerative therapies โ€ฆSee details»

DiscGenics Announces US FDA Approval to Proceed with Phase III โ€ฆ

Jul 23, 2024 DiscGenics is a privately held, late-stage clinical biopharmaceutical company developing allogeneic, cell-based regenerative therapies for musculoskeletal degeneration.See details»

FDA-Approved Study of an Allogeneic Disc Progenitor Cell โ€ฆ

Jul 9, 2024 DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, โ€ฆSee details»

DiscGenics - Golden

DiscGenics is led by a team of medical device and biologics industry executives, practicing clinicians and innovators in orthopedics, spinal and neurosurgical markets. DiscGenics is โ€ฆSee details»

Discogenic Cells โ€” DiscGenics

DiscGenicsโ€™ cell isolation and manufacturing process is protected globally by over 40 issued patents and 30 additional patents pending, and is trade secret protected. Scientific โ€ฆSee details»

DNA organization offers clues for advancing stem cell therapy

4 days ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll โ€ฆSee details»

linkstock.net © 2022. All rights reserved